CARDIOSTER financials
A multi-period view of the public annual-account figures reported for CARDIOSTER, with comparable measures and links to available source documents.
Company overviewRegistry number
0809715418
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for CARDIOSTER
2025 versus 2024
- Operating line
- €374,502
- EBITDA
- €372,924
- Total assets
- €730,327
- Equity
- €583,286
+12%
+12.5%
+23.5%
+37.1%
EBITDA margin +99.6% · Equity ratio +79.9%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €374,502 | €372,924 | €730,327 | €583,286 | - |
| 202431 Dec 2024 | €334,308 | €331,612 | €591,222 | €425,533 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.